MILESTONE PHARMACEUTICALS INC. THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT Dated as of October 15, 2018Registration Rights Agreement • December 21st, 2018 • Milestone Pharmaceuticals Inc. • Pharmaceutical preparations
THIS THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT is made as of October 15, 2018 between Milestone Pharmaceuticals Inc. (the “Corporation”), a legal person existing under the laws of the Province of Québec, represented herein by Joseph Oliveto, its Chief Executive Officer, duly authorized for the purposes hereof as he so declares, and the holders of Class A Preferred Shares, the holders of Class B Preferred Shares, the holders of Class C Preferred Shares and the holders of Class D Preferred Shares of the Corporation listed on Schedule A, as such Schedule may be amended from time to time (collectively, the “Investors”).
BY-LAW NO. 2017-1 a by-law relating generally to the transaction of the business and affairs of MILESTONE PHARMACEUTICALS INC. MILESTONE PHARMACEUTIQUES INC. (the “Corporation”)Milestone Pharmaceuticals Inc. • December 21st, 2018 • Pharmaceutical preparations
